Case Studies — The Bracken Group

Bridging the Gap: How Bracken Supports Biotech and Pharma Companies Using Imaging Endpoints in Clinical Trials

Written by Colin G. Miller | Oct 28, 2022 2:15:00 PM

The Scenario

As the use of imaging endpoints in clinical trials has increased steadily over the last 30 years, an imaging core lab (ICL) — or sometimes called an imaging CRO — is often involved.

Sponsors using imaging endpoints in clinical trials are often dependent on ICLs they lack the expertise to oversee. That knowledge gap creates real risk: inadequate oversight of ICLs can lead to data quality failures, protocol misalignment, and costly delays....  

Bracken's imaging experts bridge that gap: protecting data integrity, timelines, and submissions.